Dogecoin Cash, Inc (DOGP) Fair Value & Analysis
Healthcare · US · Market cap $1.3M
Dogecoin Cash, Inc
DOGP · US
Fair value as of: Jun 23, 2026
From 3 valuation models · updated 48 days ago
Share price −9.6% over the past month.
Below-average quality, screening 13% undervalued on our models.
What matters now
- The price is below even our cautious bear case ($0.0085). The market is more pessimistic than our downside scenario.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 23, 2026.
How to read this chart
60‑month range $0.0023 – $0.5978 · the $0.0075 price screens below the $0.0085 fair value. Dashed = 300-day average. As of Jun 23, 2026.
Analysis
Dogecoin Cash, Inc (DOGP) currently trades at $0.0075, while our model-based Fair Value estimate is $0.0085, implying the stock looks roughly 13.3% undervalued today. The Quality Score stands at 25/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, Dogecoin Cash, Inc generated revenue of $747K at a net margin of -89.3%. Revenue grew 4.6% year over year. Fundamentals as of Jun 23, 2026
For context, the median of 10 Healthcare peers we cover trades at -53% fair-value upside, at 13%, DOGP screens cheaper than that median.
Notify me when DOGP reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jun 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 25 · Market factors (momentum, volatility) 0
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians.
Full company description
Dogecoin Cash, Inc., through its subsidiaries, provides online telehealth referral services through the PrestoDoctor platform in the United States. The company offers the technology platform and administrative support that facilitate telemedicine consultations between patients and licensed physicians. In addition, it maintains cannabis-related intellectual property. The company was formerly known as Cannabis Sativa, Inc. and changed its name to Dogecoin Cash, Inc. in November 2024. Dogecoin Cash, Inc. is based in Mesquite, Nevada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dogecoin Cash, Inc reported revenue of $739K in FY2025 versus $1.8M in FY2021, a compound −20.4%/yr. Reported net income was −$573K in FY2025.
Watch DOGP: get an alert when its fair value changes →
Peer Group
Health Information Services · 126 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Jun 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $190.12 | $95.12 | -50% |
| Pro Medicus Limited PME | A$194.84 | A$23.74 | -88% |
| BrightSpring Health Services, Inc BTSG | $68.16 | $21.31 | -69% |
| HealthEquity, Inc HQY | $97.67 | $56.63 | -42% |
| Hinge Health, Inc HNGE | $88.80 | $24.03 | -73% |
| 10x Genomics, Inc TXG | $45.75 | $17.18 | -62% |
| Waystar Holding WAY | $22.69 | $12.86 | -43% |
| Doximity, Inc DOCS | $22.21 | $17.18 | -23% |
| Privia Health Group PRVA | $28.10 | $5.30 | -81% |
| Inventurus Knowledge Solutions Limited IKS | ₹1,846 | ₹860.28 | -53% |
Compare Dogecoin Cash, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Dogecoin Cash, Inc (DOGP) overvalued or undervalued?
What is the fair value of DOGP?
What is the quality score of DOGP?
What is the revenue of Dogecoin Cash, Inc (DOGP)?
What is the net profit margin of DOGP?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Dogecoin Cash, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.